Back to Directory
Antigenika
Founded 2024
Oral small-molecule treatment for snakebite envenoming
Antigenika is a biopharmaceutical company developing an oral treatment for snakebite envenoming. Its approach combines repurposed small-molecule drugs in a tablet intended for use soon after a bite, including where the snake species is unknown. The programme grew out of venom pharmacology research at the University of Reading. The company reports completing preclinical testing against multiple venoms and is preparing its first safety study in healthy volunteers.